[Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
D000328:Adult; D001707:Biopsy, Needle; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D005260:Female; D006506:Hepatitis A / Q000209:etiology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007565:Jaundice / Q000139:chemically induced*; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin
Tolérance hépatique des traitements antituberculeux incluant la rifampicine. Etude sur 214 observations.